Clin2
NCT07654296Likely a fitNot yet recruiting

Testing a new pain medicine after ureteroscopy

Opioid Consumption, PostoperativeMultimodal AnalgesiaUreteroscopyUreteral StentsUreteral Stent-Related Symptoms

Treatments studied

Part of Kidney & urinary, Pain clinical trials.

This trial tests a new pain medication called suzetrigine to see how well it reduces pain after ureteroscopy, a common procedure for kidney stones. If you are having this surgery, you may be able to join and get a treatment that could help you manage pain with fewer side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
100 people
Ages
21 years to 80 years
Study type
Interventional

Who can take part

  • You are between 21 and 80 years old.
  • You are scheduled for a ureteroscopy (a scope procedure to treat kidney stones or other issues in the ureter).
  • You can make your own medical decisions and sign the consent form.
  • You do not use opioids regularly before surgery.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07672015Recruiting· Phase 4
Testing a new pain drug in surgery patients at risk for opioid dependence

This trial tests a new painkiller called suzetrigine for post-surgery pain. It's designed for people whose medical records suggest they may have a higher chance of needing strong painkillers (opioids) long after surgery. We want to see if suzetrigine works better at preventing that.

La Jolla, California
NCT07226700Recruiting· Phase 3
Suzetrigine for pain after hip replacement surgery

This study tests an investigational pain medicine called suzetrigine to see how well it controls pain after total hip replacement surgery. It is for adults 18–80 who are having a first-time hip replacement and can receive spinal anesthesia.

New York, New York
NCT07534709Not yet recruiting· Phase 4
Suzetrigine for Pain Relief After Cesarean Delivery Without Opioids

This study tests whether a new pain medication called suzetrigine can help you recover comfortably after a cesarean delivery without needing strong opioid painkillers. You'll receive the study drug and complete follow-up check-ins for two weeks after surgery.

Austin, Texas
NCT07539623Recruiting· Phase 3
Pain relief with suzetrigine after heart or weight-loss surgery

This study tests whether suzetrigine, a new pain medication, can reduce the need for opioids (strong painkillers) after cardiac or bariatric surgery. The goal is to help patients manage pain with fewer opioid-related side effects.

New York, New York
NCT07463430Enrolling by invitation· Phase 4
Suzetrigine for pain after non-mastectomy breast surgery

This trial tests a new pain medication, suzetrigine, for people having breast surgery (not mastectomy) who are expected to have moderate pain. It checks if this drug works well compared to standard options.

San Diego, California
NCT07600697Not yet recruiting· Phase 4
Suzetrigine for Pain After Vaginal Pelvic Surgery

This study tests whether a new pain medication called suzetrigine can reduce the need for opioids (strong painkillers) after vaginal pelvic reconstructive surgery. The goal is to manage post-surgery pain safely with fewer opioids.

Los Angeles, California

Hear when a new Opioid Consumption, Postoperative trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.